Cell responses regulated by early reorganization of actin cytoskeleton

FEBS Letters

Volumn 582, Issue 14, 2008, Pages 2120-2127

  Papakonstanti, E A ^a   Stournaras, C ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Actin cytoskeleton; Cell response; GPCRs; Ion channel; Membrane androgen receptor; TNF

Indexed keywords

ACTIN; ION CHANNEL; MYOSIN ADENOSINE TRIPHOSPHATASE; RAC PROTEIN; RHO FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ACTIN FILAMENT; CELL FUNCTION; CELL INTERACTION; CELL INVASION; CELL MIGRATION; CYTOSKELETON; DESMOSOME; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FILOPODIUM; LAMELLIPODIUM; NONHUMAN; PLEIOTROPY; POLARIZATION; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION;

ACTINS; APOPTOSIS; CELL MOVEMENT; HUMANS; ION CHANNELS; LIGANDS; MICROFILAMENTS; NEOPLASM INVASIVENESS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, STEROID; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 44449149681     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2008.02.064     Document Type: Short Survey

References (152)

1. Stossel T.P. Contribution of actin to the structure of the cytoplasmic matrix. J. Cell Biol. 99 (1984) 15s-21s
2. Begg D.A., Rodewald R., and Rebhun L.I. The visualization of actin filament polarity in thin sections. Evidence for the uniform polarity of membrane-associated filaments. J. Cell Biol. 79 (1978) 846-852
3. Bonder E.M., and Mooseker M.S. Direct electron microscopic visualization of barbed end capping and filament cutting by intestinal microvillar 95-kdalton protein (villin): a new actin assembly assay using the limulus acrosomal process. J. Cell Biol. 96 (1983) 1097-1107
4. Bonder E.M., Fishkind D.J., and Mooseker M.S. Direct measurement of critical concentrations and assembly rate constants at the two ends of an actin filament. Cell 34 (1983) 491-501
5. Pollard T.D., and Borisy G.G. Cellular motility driven by assembly and disassembly of actin filaments. Cell 112 (2003) 453-465
6. Janmey P.A., Lamb J., Allen P.G., and Matsudaira P.T. Phosphoinositide-binding peptides derived from the sequences of gelsolin and villin. J. Biol. Chem. 267 (1992) 11818-11823
7. Yin H.L., and Janmey P.A. Phosphoinositide regulation of the actin cytoskeleton. Annu. Rev. Physiol. 65 (2003) 761-789
8. Maciver S. Myosin II function in non-muscle cells. Bioessays 18 (1996) 179-182
9. Yumura S., and Uyeda T.Q. Myosins and cell dynamics in cellular slime molds. Int. Rev. Cytol. 224 (2003) 173-225
10. Parent C.A. Making all the right moves: chemotaxis in neutrophils and Dictyostelium. Curr. Opin. Cell Biol. 16 (2004) 4-13
11. Ridley A.J., Paterson H.F., Johnston C.L., Diekmann D., and Hall A. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70 (1992) 401-410
12. Ridley A.J., and Hall A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell 70 (1992) 389-399
13. Ridley A.J. Rho family proteins: coordinating cell responses. Trends Cell Biol. 11 (2001) 471-477
14. Ridley A.J. Rho GTPases and cell migration. J. Cell Sci. 114 (2001) 2713-2722
15. Etienne-Manneville S., and Hall A. Rho GTPases in cell biology. Nature 420 (2002) 629-635
16. Raftopoulou M., and Hall A. Cell migration: Rho GTPases lead the way. Dev. Biol. 265 (2004) 23-32
17. Barber M.A., and Welch H.C.E. PI3K and RAC signalling in leukocyte and cancer cell migration. Bull. du Cancer, Electron. J. Oncol. 93 (2006) 10044-10052
18. Charest P.G., and Firtel R.A. Feedback signaling controls leading-edge formation during chemotaxis. Curr. Opin. Genet. Dev. 16 (2006) 339-347
19. Nobes C.D., and Hall A. Rho, rac and cdc42 GTPases: regulators of actin structures, cell adhesion and motility. Biochem. Soc. Trans. 23 (1995) 456-459
20. Machesky L.M., and Hall A. Rho: a connection between membrane receptor signalling and the cytoskeleton. Trends Cell Biol. 6 (1996) 304-310
21. Hall A. Rho GTPases and the actin cytoskeleton. Science 279 (1998) 509-514
22. Nobes C.D., and Hall A. Rho GTPases control polarity, protrusion, and adhesion during cell movement. J. Cell Biol. 144 (1999) 1235-1244
23. Arthur W.T., and Burridge K. RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity. Mol. Biol. Cell 12 (2001) 2711-2720
24. Pixley F.J., Xiong Y., Yu R.Y.-L., Sahai E.A., Stanley E.R., and Ye B.H. BCL6 suppresses RhoA activity to alter macrophage morphology and motility. J. Cell Sci. 118 (2005) 1873-1883
25. Wong K., Pertz O., Hahn K., and Bourne H. Neutrophil polarization: spatiotemporal dynamics of RhoA activity support a self-organizing mechanism. Proc. Natl. Acad. Sci. USA 103 (2006) 3639-3644
26. Sander E.E., ten Klooster J.P., van Delft S., van der Kammen R.A., and Collard J.G. Rac downregulates rho activity: reciprocal balance between both GTPases determines cellular morphology and migratory behavior. J. Cell Biol. 147 (1999) 1009-1022
27. Burridge K., and Wennerberg K. Rho and Rac take center stage. Cell 116 (2004) 167-179
28. Papakonstanti E.A., Ridley A.J., and Vanhaesebroeck B. The p110δ isoform of PI 3-kinase negatively controls RhoA and PTEN. EMBO J. 26 (2007) 3050-3061
29. Chan A.Y., Raft S., Bailly M., Wyckoff J.B., Segall J.E., and Condeelis J.S. EGF stimulates an increase in actin nucleation and filament number at the leading edge of the lamellipodia in mammary adenocarcinoma cells. J. Cell Sci. 111 (1998) 199-211
30. Svitkina T.M., and Borisy G.G. Arp2/3 complex and actin depolymerizing factor/cofilin in dendritic organization and treadmilling of actin filament array in lamellipodia. J. Cell Biol. 145 (1999) 1009-1026
31. Bailly M., Macaluso F., Cammer M., Chan A., Segall J.E., and Condeelis J.S. Relationship between Arp2/3 complex and the barbed ends of actin filaments at the leading edge of carcinoma cells after epidermal growth factor stimulation. J. Cell Biol. 145 (1999) 331-345
32. Condeelis J. How is actin polymerization nucleated in vivo?. Trends Cell Biol. 11 (2001) 288-293
33. Weaver A.M., Heuser J.E., Karginov A.V., Lee W.-l., Parsons J.T., and Cooper J.A. Interaction of cortactin and N-WASp with Arp2/3 complex. Curr. Biol. 12 (2002) 1270-1278
34. Khurana S., Tomar A., George S.P., Wang Y., Siddiqui M.R., Guo H., Tigyi G., and Mathew S. Autotaxin and lysophosphatidic acid stimulate intestinal cell motility by redistribution of the actin modifying protein villin to the developing lamellipodia. Exp. Cell Res. 314 (2008) 530-542
35. Tomar A., George S., Kansal P., Wang Y., and Khurana S. Interaction of phospholipase C-{gamma}1 with villin regulates epithelial cell migration. J. Biol. Chem. 281 (2006) 31972-31986
36. Yamashiro S., Yamakita Y., Ono S., and Matsumura F. Fascin, an actin-bundling protein, induces membrane protrusions and increases cell motility of epithelial cells. Mol. Biol. Cell 9 (1998) 993-1006
37. Small J.V., Rottner K., and Kaverina I. Functional design in the actin cytoskeleton. Curr. Opin. Cell Biol. 11 (1999) 54-60
38. Svitkina T.M., Bulanova E.A., Chaga O.Y., Vignjevic D.M., Kojima S.-i., Vasiliev J.M., and Borisy G.G. Mechanism of filopodia initiation by reorganization of a dendritic network. J. Cell Biol. 160 (2003) 409-421
39. Weaver A. Invadopodia: specialized cell structures for cancer invasion. Clin. Exp. Metastas. 23 (2006) 97-105
40. Rao J. Targeting actin remodeling profiles for the detection and management of urothelial cancers - a perspective for bladder cancer research. Front. Biosci. 7 (2002) e1-e8
41. Notarangelo L.D., and Ochs H.D. Wiskott-Aldrich syndrome: a model for defective actin reorganization, cell trafficking and synapse formation. Curr. Opin. Immun. 15 (2003) 585-591
42. Hildebrand J.D., and Soriano P. Shroom, a PDZ domain-containing actin-binding protein, is required for neural tube morphogenesis in mice. Cell 99 (1999) 485-497
43. Xu W., Baribault H., and Adamson E.D. Vinculin knockout results in heart and brain defects during embryonic development. Development 125 (1998) 327-337
44. Nunoi H., Yamazaki T., Tsuchiya H., Kato S., Malech H.L., Matsuda I., and Kanegasaki S. A heterozygous mutation of beta-actin associated with neutrophil dysfunction and recurrent infection. Proc. Natl. Acad. Sci. 96 (1999) 8693-8698
45. Vandekerckhove J., Leavitt J., Kakunaga T., and Weber K. Coexpression of a mutant [beta]-actin and the two normal [beta]- and [gamma]-cytoplasmic actins in a stably transformed human cell line. Cell 22 (1980) 893-899
46. Sadano H., Taniguchi S., Kakunaga T., and Baba T. cDNA cloning and sequence of a new type of actin in mouse B16 melanoma. J. Biol. Chem. 263 (1988) 15868-15871
47. Kaneda A., Kaminishi M., Nakanishi Y., Sugimura T., and Ushijima T. Reduced expression of the insulin-induced protein 1 and p41 Arp2/3 complex genes in human gastric cancers. Int. J. Cancer 100 (2002) 57-62
48. Janke J., et al. Suppression of tumorigenicity in breast cancer cells by the microfilament protein profilin 1. J. Exp. Med. 191 (2000) 1675-1686
49. Shieh D.B., Godleski J., Herndon J.E.n., Azuma T., Mercer H., Sugarbaker D.J., and Kwiatkowski D.J. Cell motility as a prognostic factor in Stage I nonsmall cell lung carcinoma: the role of gelsolin expression. Cancer 85 (1999) 47-57
50. Harri V., et al. Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma. Urology 61 (2003) 845-850
51. Winston J.S., Asch H.L., Zhang P.J., Edge S.B., Hyland A., and Asch B.B. Downregulation of gelsolin correlates with the progression to breast carcinoma. Breast Cancer Res. Treat. 65 (2001) 11-21
52. Martoglio A.M., Tom B.D., Starkey M., Corps A.N., Charnock-Jones D.S., and Smith S.K. Changes in tumorigenesis- and angiogenesis-related gene transcript abundance profiles in ovarian cancer detected by tailored high density cDNA arrays. Mol. Med. 6 (2000) 750-765
53. Ridley A.J. Rho proteins and cancer. Breast Cancer Res. Treat. 84 (2004) 13-19
54. Somlyo A.V., Bradshaw D., Ramos S., Murphy C., Myers C.E., and Somlyo A.P. Rho-kinase inhibitor retards migration and in vivo dissemination of human prostate cancer cells. Biochem. Biophys. Res. Commun. 269 (2000) 652-659
55. Yoshioka K., Foletta V., Bernard O., and Itoh K. A role for LIM kinase in cancer invasion. Proc. Natl. Acad. Sci. 100 (2003) 7247-7252
56. Adam L., Vadlamudi R., Mandal M., Chernoff J., and Kumar R. Regulation of microfilament reorganization and invasiveness of breast cancer cells by kinase dead p21-activated kinase-1. J. Biol. Chem. 275 (2000) 12041-12050
57. Nelson W.J. Regulation of cell surface polarity in renal epithelia. Pediatr. Nephrol. 7 (1993) 599-604
58. Brown D., and Stow J.L. Protein trafficking and polarity in kidney epithelium: from cell biology to physiology. Physiol. Rev. 76 (1996) 245-297
59. Yeaman C., Grindstaff K.K., and Nelson W.J. New perspectives on mechanisms involved in generating epithelial cell polarity. Physiol. Rev. 79 (1999) 73-98
60. Stein M.-P., Wandinger-Ness A., and Roitbak T. Altered trafficking and epithelial cell polarity in disease. Trends Cell Biol. 12 (2002) 374-381
61. - cotransport system by reorganization of the actin filaments in Ehrlich ascites tumor cells. Biochim. Biophys. Acta 1110 (1992) 199-201
62. + channels by protein kinase A requires actin filaments. AJP - Cell Physiol. 265 (1993) C224-C233
63. Cantiello H.F., Prat A.G., Bonventre J.V., Cunningham C.C., Hartwig J.H., and Ausiello D.A. Actin-binding protein contributes to cell volume regulatory ion channel activation in melanoma cells. J. Biol. Chem. 268 (1993) 4596-4599
64. Ding G.H., Franki N., Condeelis J., and Hays R.M. Vasopressin depolymerizes F-actin in toad bladder epithelial cells. AJP - Cell Physiol. 260 (1991) C9-C16
65. Simon H., Gao Y., Franki N., and Hays R.M. Vasopressin depolymerizes apical F-actin in rat inner medullary collecting duct. AJP - Cell Physiol. 265 (1993) C757-C762
66. Mazzochi C., Benos D.J., and Smith P.R. Interaction of epithelial ion channels with the actin-based cytoskeleton. AJP - Renal Physiol. 291 (2006) F1113-F1122
67. Sullivan L.P. Physiological of the Kidney (1974), Henrey Kimpton Publishers, London
68. Kellerman P.S., Clark R.A., Hoilien C.A., Linas S.L., and Molitoris B.A. Role of microfilaments in maintenance of proximal tubule structural and functional integrity. AJP - Renal Physiol. 259 (1990) F279-F285
69. Murer H., and Biber J. Renal sodium-phosphate cotransport. Curr. Opin. Nephrol. Hypertens. 3 (1994) 504-510
70. Murer H., Werner A., Reshkin S., Wuarin F., and Biber J. Cellular mechanisms in proximal tubular reabsorption of inorganic phosphate. AJP - Cell Physiol. 260 (1991) C885-C899
71. Kempson S.A. Peptide hormone action on renal phosphate handling. Kidney Int. 49 (1996) 1005-1009
72. +/Pi co-transport alters rapidly cytoskeletal protein polymerization dynamics in opossum kidney cells. Biochem. J. 315 (1996) 241-247
73. +/Pi cotransport up-regulation. Mol. Med. 6 (2000) 303-318
74. Vanhaesebroeck B., et al. Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 70 (2001) 535-602
75. Ridley A.J. Rho proteins, PI3-kinases, and monocyte/macrophage motility. FEBS Lett. 498 (2001) 168-171
76. Knaus U.G., and Bokoch G.M. The p21Rac/Cdc42-activated kinases (PAKs). Int. J. Biochem. Cell Biol. 30 (1998) 857-862
77. Kjoller L., and Hall A. Signaling to Rho GTPases. Exp. Cell Res. 253 (1999) 166-179
78. Jones G.E., Prigmore E., Calvez R., Hogan C., Dunn G.A., Hirsch E., Wymann M.P., and Ridley A.J. Requirement for PI 3-kinase [gamma] in macrophage migration to MCP-1 and CSF-1. Exp. Cell Res. 290 (2003) 120-131
79. Schlyer S., and Horuk R. I want a new drug: G-protein coupled receptors in drug development. Drug Discov. Today 11 (2006) 481-493
80. Miller A.F., and Falke J.J. Chemotaxis receptors and signaling. Adv Protein Chem. 68 (2004) 393-444
81. Weiss-Haljiti C., et al. Involvement of phosphoinositide 3-kinase {gamma}, Rac, and PAK signaling in chemokine-induced macrophage migration. J. Biol. Chem. 279 (2004) 43273-43284
82. Johnson E.N., and Druey K.M. Heterotrimeric G protein signaling: Role in asthma and allergic inflammation. J. Allergy Clin. Immun. 109 (2002) 592-602
83. Houshmand P., and Zlotnik A. Therapeutic applications in the chemokine superfamily. Curr. Opin. Chem. Biol. 7 (2003) 457-460
84. Rozengurt E. Mitogenic signaling pathways induced by G protein-coupled receptors. J Cell Physiol. 213 (2007) 589-602
85. Kelly P., Casey P.J., and Meigs T.E. Biologic functions of the G12 subfamily of heterotrimeric g proteins: growth, migration, and metastasis. Biochemistry 46 (2007) 6677-6687
86. Sah V.P., Seasholtz T.M., Sagi S.A., and Brown J.H. The role of Rho in G protein-coupled receptor signal transduction. Annu. Rev. Pharmacol. Toxicol. 40 (2000) 459-489
87. Parsons J.T. Focal adhesion kinase: the first ten years. J. Cell Sci. 116 (2003) 1409-1416
88. Suzuki N., Nakamura S., Mano H., and Kozasa T. Galpha 12 activates Rho GTPase through tyrosine-phosphorylated leukemia-associated RhoGEF. Proc. Natl. Acad. Sci. 100 (2003) 733-738
89. Kourlas P.J., et al. Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia. Proc. Natl. Acad. Sci. 97 (2000) 2145-2150
90. Kozasa T., Jiang X., Hart M.J., Sternweis P.M., Singer W.D., Gilman A.G., Bollag G., and Sternweis P.C. p115 RhoGEF, a GTPase activating protein for Galpha12 and Galpha13. Science 280 (1998) 2109-2111
91. Hart M.J., Jiang X., Kozasa T., Roscoe W., Singer W.D., Gilman A.G., Sternweis P.C., and Bollag G. Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by Galpha13. Science 280 (1998) 2112-2114
92. Vogt S., Grosse R., Schultz G., and Offermanns S. Receptor-dependent RhoA activation in G12/G13-deficient Cells: genetic evidence for an involvement of Gq/G11. J. Biol. Chem. 278 (2003) 28743-28749
93. Lutz S., Freichel-Blomquist A., Yang Y., Rumenapp U., Jakobs K.H., Schmidt M., and Wieland T. The guanine nucleotide exchange factor p63RhoGEF, a specific link between Gq/11-coupled receptor signaling and RhoA. J. Biol. Chem. 280 (2005) 11134-11139
94. Burridge K., and Chrzanowska-Wodnicka M. Focal adhesions, contractility, and signaling. Annu. Rev. Cell Dev. Biol. 12 (1996) 463-518
95. Zachary I., and Rozengurt E. Focal adhesion kinase (p125FAK): a point of convergence in the action of neuropeptides, integrins, and oncogenes. Cell 71 (1992) 891-894
96. Rozengurt E. Signal transduction pathways in the mitogenic response to G protein-coupled neuropeptide receptor agonists. J. Cell Physiol. 177 (1998) 507-517
97. Hunger-Glaser I., Salazar E.P., Sinnett-Smith J., and Rozengurt E. Bombesin, lysophosphatidic acid, and epidermal growth factor rapidly stimulate focal adhesion kinase phosphorylation at Ser-910: requirement for ERK activation. J. Biol. Chem. 278 (2003) 22631-22643
98. Hunger-Glaser I., Fan R.S., Perez-Salazar E., and Rozengurt E. PDGF and FGF induce focal adhesion kinase (FAK) phosphorylation at Ser-910: dissociation from Tyr-397 phosphorylation and requirement for ERK activation. J. Cell Physiol. 200 (2004) 213-222
99. 2+/calmodulin-dependent kinase II. J. Biol. Chem. 280 (2005) 24212-24220
100. Jacamo R., Jiang X., Lunn J.A., and Rozengurt E. FAK phosphorylation at Ser-843 inhibits Tyr-397 phosphorylation, cell spreading and migration. J. Cell Physiol. 210 (2007) 436-444
101. Cant S.H., and Pitcher J.A. G protein-coupled receptor kinase 2-mediated phosphorylation of ezrin is required for G protein-coupled receptor-dependent reorganization of the actin cytoskeleton. Mol. Biol. Cell 16 (2005) 3088-3099
102. Reisine T., and Bell G.I. Molecular biology of opioid receptors. Trends Neurosci. 16 (1993) 506-510
103. Hatzoglou A., Bakogeorgou E., Hatzoglou C., Martin P.M., and Castanas E. Antiproliferative and receptor binding properties of alpha- and beta-casomorphins in the T47D human breast cancer cell line. Eur. J. Pharmacol. 310 (1996) 217-223
104. Hatzoglou A., Bakogeorgou E., Papakonstanti E., Stournaras C., Emmanouel D.S., and Castanas E. Identification and characterization of opioid and somatostatin binding sites in the opossum kidney (OK) cell line and their effect on growth. J. Cell Biochem. 63 (1996) 410-421
105. Kampa M., Bakogeorgou E., Hatzoglou A., Damianaki A., Martin P.-M., and Castanas E. Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors. Eur. J. Pharmacol. 335 (1997) 255-265
106. Mercadante S., and Arcuri E. Opioids and renal function. J. Pain 5 (2004) 2-19
107. Castanas E., Bourhim N., Giraud P., Boudouresque F., Cantau P., and Oliver C. Interaction of opiates with opioid binding sites in the bovine adrenal medulla: II. Interaction with kappa sites. J. Neurochem. 45 (1985) 688-699
108. Papakonstant E.A., Bakogeorgou E., Castanas E., Emmanouel D.S., Hartig R., and Stournaras C. Early alterations of actin cytoskeleton in OK cells by opioids. J. Cell Biochem. 70 (1998) 60-69
109. Papakonstanti E.A., and Stournaras C. Association of PI-3 kinase with PAK1 leads to actin phosphorylation and cytoskeletal reorganization. Mol. Biol. Cell 13 (2002) 2946-2962
110. Madge L.A., and Pober J.S. A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFkappa B in human endothelial cells. J. Biol. Chem. 275 (2000) 15458-15465
111. Baud V., and Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11 (2001) 372-377
112. Natoli G., Costanzo A., Guido F., Moretti F., and Levrero M. Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling. Biochem. Pharmacol. 56 (1998) 915-920
113. Koukouritaki S.B., Vardaki E.A., Papakonstanti E.A., Lianos E., Stournaras C., and Emmanouel D.S. TNF-alpha induces actin cytoskeleton reorganization in glomerular epithelial cells involving tyrosine phosphorylation of paxillin and focal adhesion kinase. Mol. Med. 5 (1999) 382-392
114. Stockton R.A., Schaefer E., and Schwartz M.A. p21-activated kinase regulates endothelial permeability through modulation of contractility. J. Biol. Chem. 279 (2004) 46621-46630
115. Gadea G., Roger L., Anguille C., de Toledo M., Gire V., and Roux P. TNF{alpha} induces sequential activation of Cdc42- and p38/p53-dependent pathways that antagonistically regulate filopodia formation. J. Cell Sci. 117 (2004) 6355-6364
116. Osiak A.-E., Zenner G., and Linder S. Subconfluent endothelial cells form podosomes downstream of cytokine and RhoGTPase signaling. Exp. Cell Res. 307 (2005) 342-353
117. Wójciak-Stothard B., Entwistle A., Garg R., and Ridley A.J. Regulation of TNF-alpha-induced reorganization of the actin cytoskeleton and cell-cell junctions by Rho, Rac, and Cdc42 in human endothelial cells. J. Cell Physiol. 176 (1998) 150-165
118. Rodriguez P., Heyman M., Candalh C., Blaton M.A., and Bouchaud C. Tumour necrosis factor-[alpha] induces morphological and functional alterations of intestinal HT29 cl.19A cell monolayers. Cytokine 7 (1995) 441-448
119. Nusrat A., Turner J.R., and Madara J.L. Molecular physiology and pathophysiology of tight junctions: IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells. AJP - Gastr. Liver Physiol. 279 (2000) G851-G857
120. Chen L.-W., Egan L., Li Z.-W., Greten F.R., Kagnoff M.F., and Karin M. The two faces of IKK and NF-[kappa]B inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat. Med. 9 (2003) 575-581
121. Baert F.J., D'Haens G.R., Peeters M., Hiele M.I., Schaible T.F., Shealy D., Geboes K., and Rutgeerts P.J. Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis. Gastroenterology 116 (1999) 22-28
122. Clayburgh D.R., Shen L., and Turner J.R. A porous defense: the leaky epithelial barrier in intestinal disease. Lab. Invest. 84 (2004) 282-291
123. Shen L., and Turner J.R. Actin depolymerization disrupts tight junctions via caveolae-mediated endocytosis. Mol. Biol. Cell 16 (2005) 3919-3936
124. Nusrat A., et al. Rho protein regulates tight junctions and perijunctional actin organization in polarized epithelia. Proc. Natl. Acad. Sci. 92 (1995) 10629-10633
125. Stevenson B.R., and Begg D.A. Concentration-dependent effects of cytochalasin D on tight junctions and actin filaments in MDCK epithelial cells. J. Cell Sci. 107 (1994) 367-375
126. Mullin J.M., Laughlin K.V., Marano C.W., Russo L.M., and Soler A.P. Modulation of tumor necrosis factor-induced increase in renal (LLC-PK1) transepithelial permeability. AJP - Renal Physiol. 263 (1992) F915-F924
127. Marano C.W., Lewis S.A., Garulacan L.A., Soler A.P., and Mullin J.M. Tumor necrosis factor-α increases sodium and chloride conductance across the tight junction of CACO-2 BBE, a human intestinal epithelial cell line. J. Memb. Biol. 161 (1998) 263-274
128. Gitter A.H., Bendfeldt K., Schulzke J.-D., and Fromm M. Leaks in the epithelial barrier caused by spontaneous and TNF-{alpha}-induced single-cell apoptosis. FASEB J. 14 (2000) 1749-1753
129. Bruewer M., Luegering A., Kucharzik T., Parkos C.A., Madara J.L., Hopkins A.M., and Nusrat A. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J. Immun. 171 (2003) 6164-6172
130. Mankertz J., Tavalali S., Schmitz H., Mankertz A., Riecken E.O., Fromm M., and Schulzke J.D. Expression from the human occludin promoter is affected by tumor necrosis factor alpha and interferon gamma. J. Cell Sci. 113 (2000) 2085-2090
131. Zolotarevsky Y., Hecht G., Koutsouris A., Gonzalez D.E., Quan C., Tom J., Mrsny R.J., and Turner J.R. A membrane-permeant peptide that inhibits MLC kinase restores barrier function in in vitro models of intestinal disease. Gastroenterology 123 (2002) 163-172
132. Wang F., Graham W.V., Wang Y., Witkowski E.D., Schwarz B.T., and Turner J.R. Interferon-γ and tumor necrosis factor-α synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am. J. Pathol. 166 (2005) 409-419
133. Ma T.Y., Boivin M.A., Ye D., Pedram A., and Said H.M. Mechanism of TNF-alpha modulation of Caco-2 intestinal epithelial tight junction barrier: role of myosin light-chain kinase protein expression. AJP - Gastr. Liver Physiol. 288 (2005) G422-G430
134. McKenzie J.A., and Ridley A.J. Roles of Rho/ROCK and MLCK in TNF-alpha-induced changes in endothelial morphology and permeability. J. Cell Physiol. 213 (2007) 221-228
135. Healy E., Leonard M., Madrigal-Estebas L., O'Farrelly C., Watson A.J., and Ryan M.P. Factors produced by activated leukocytes alter renal epithelial cell differentiation. Kidney Int. 56 (1999) 1266-1269
136. Anders H.-J., Vielhauer V., and Schlondorff D. Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kidney Int. 63 (2003) 401-415
137. Thurman J.M. Triggers of inflammation after renal ischemia/reperfusion. Clin. Immunol. 123 (2007) 7-13
138. Versteilen A.M., Di Maggio F., Leemreis J.R., Groeneveld A.B., Musters R.J., and Sipkema P. Molecular mechanisms of acute renal failure following ischemia/reperfusion. Int. J. Artif. Organs 27 (2004) 1019-1029
139. Papakonstanti E.A., and Stournaras C. Tumor necrosis factor-alpha promotes survival of opossum kidney cells via Cdc42-induced phospholipase C-gamma1 activation and actin filament redistribution. Mol. Biol. Cell 15 (2004) 1273-1286
140. Simoncini T., et al. Estrogen receptor {alpha} interacts with G{alpha}13 to drive actin remodeling and endothelial cell migration via the RhoA/Rho kinase/Moesin pathway. Mol. Endocrinol. 20 (2006) 1756-1771
141. Koukouritaki S.B., Gravanis A., and Stournaras C. Tyrosine phosphorylation of focal adhesion kinase and paxillin regulates the signaling mechanism of the rapid nongenomic action of dexamethasone on actin cytoskeleton. Mol. Med. 5 (1999) 731-742
142. Falkenstein E., Norman A.W., and Wehling M. Mannheim classification of nongenomically initiated (rapid) steroid action(s). J. Clin. Endocrinol. Metab. 85 (2000) 2072-2075
143. Chambliss K.L., and Shaul P.W. Rapid activation of endothelial NO synthase by estrogen: evidence for a steroid receptor fast-action complex (SRFC) in caveolae. Steroids 67 (2002) 413-419
144. Schmidt B.M.W., Gerdes D., Feuring M., Falkenstein E., Christ M., and Wehling M. Rapid, nongenomic steroid actions: a new age?. Front. Neuroendocrinol. 21 (2000) 57-94
145. Losel R., and Wehling M. Nongenomic actions of steroid hormones. Nat. Rev. Mol. Cell Biol. 4 (2003) 46-56
146. Norman A.W., Mizwicki M.T., and Norman D.P. Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat. Rev. Drug Discov. 3 (2004) 27-41
147. Benten W.P.M., Lieberherr M., Giese G., Wrehlke C., Stamm O., Sekeris C.E., Mossmann H., and Wunderlich F. Functional testosterone receptors in plasma membranes of T cells. FASEB J. 13 (1999) 123-133
148. Kampa M., Papakonstanti E.A., Hatzoglou A., Stathopoulos E.N., Stournaras C., and Castanas E. The human prostate cancer cell line LNCaP bears functional membrane testosterone receptors that increase PSA secretion and modify actin cytoskeleton. FASEB J. 16 (2002) 1429-1431
149. Hatzoglou A., et al. Membrane androgen receptor activation induces apoptotic regression of human prostate cancer cells in vitro and in vivo. J. Clin. Endocrinol. Metab. 90 (2005) 893-903
150. Kampa M., et al. Activation of membrane androgen receptors potentiates the antiproliferative effects of paclitaxel on human prostate cancer cells. Mol. Cancer Therap. 5 (2006) 1342-1351
151. Gatson J.W., and Singh M. Activation of a membrane-associated androgen receptor promotes cell death in primary cortical astrocytes. Endocrinology 148 (2007) 2458-2464
152. Papakonstanti E.A., Kampa M., Castanas E., and Stournaras C. A rapid, nongenomic, signaling pathway regulates the actin reorganization induced by activation of membrane testosterone receptors. Mol. Endocrinol. 17 (2003) 870-881